Le ROCE de Reliv` International, Inc. est 0.44%
Le retour sur capital utilisé (ROCE) est un ratio financier qui mesure la rentabilité d'une entreprise et l'efficacité avec laquelle son capital est utilisé.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
reliv international, inc. or reliv, is a worldwide marketer and manufacturer of nutritional supplements. the company is based near st. louis in chesterfield, mo., and its products are sold in the united states, canada, mexico, united kingdom, ireland, germany, australia, new zealand, philippines, malaysia, singapore, austria, the netherlands and indonesia. products are sold through a direct selling format, with a network over 40,000 distributors and preferred customers globally. reliv has a rating of ‘a’ by the better business bureau of the united states. reliv international, inc. is the corporation that develops, manufactures and markets reliv products. reliv independent distributors are independent contractors of reliv international, inc.